Stifel Financial’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.8M Sell
93,060
-15,193
-14% -$4.11M 0.02% 555
2025
Q4
$27.2M Sell
108,253
-10,016
-8% -$2.66M 0.02% 525
2025
Q3
$34M Sell
118,269
-8,797
-7% -$2.36M 0.03% 459
2025
Q2
$33.4M Sell
127,066
-2,753
-2% -$670K 0.03% 439
2025
Q1
$30.2M Sell
129,819
-479,125
-79% -$116M 0.03% 437
2024
Q4
$140M Buy
608,944
+14,437
+2% +$3.31M 0.15% 153
2024
Q3
$133M Buy
594,507
+8,313
+1% +$1.83M 0.14% 160
2024
Q2
$119M Buy
586,194
+3,049
+0.5% +$620K 0.13% 160
2024
Q1
$127M Buy
583,145
+12,958
+2% +$2.85M 0.15% 154
2023
Q4
$130M Buy
570,187
+21,222
+4% +$4.46M 0.16% 142
2023
Q3
$110M Sell
548,965
-39,138
-7% -$8.26M 0.16% 146
2023
Q2
$122M Buy
588,103
+25,454
+5% +$4.94M 0.17% 137
2023
Q1
$111M Buy
562,649
+20,116
+4% +$4.14M 0.16% 145
2022
Q4
$110M Buy
542,533
+19,095
+4% +$3.73M 0.16% 145
2022
Q3
$92.1M Buy
523,438
+26,977
+5% +$5.52M 0.15% 156
2022
Q2
$100M Buy
496,461
+8,496
+2% +$1.81M 0.16% 146
2022
Q1
$111M Buy
487,965
+19,205
+4% +$4.52M 0.15% 158
2021
Q4
$127M Buy
468,760
+19,806
+4% +$4.9M 0.17% 137
2021
Q3
$109M Buy
448,954
+10,214
+2% +$2.57M 0.16% 141
2021
Q2
$104M Buy
438,740
+6,234
+1% +$1.42M 0.16% 151
2021
Q1
$94.8M Buy
432,506
+23,039
+6% +$4.62M 0.16% 142
2020
Q4
$71.6M Buy
409,467
+20,932
+5% +$3.62M 0.13% 167
2020
Q3
$62.8M Buy
388,535
+32,501
+9% +$5.15M 0.13% 166
2020
Q2
$50.8M Buy
356,034
+61,338
+21% +$8.49M 0.12% 182
2020
Q1
$32.1M Buy
294,696
+231,543
+367% +$33.4M 0.09% 218
2019
Q4
$9.19M Buy
63,153
+614
+1% +$88.6K 0.02% 640
2019
Q3
$9.04M Buy
62,539
+3,460
+6% +$505K 0.02% 598
2019
Q2
$8.77M Sell
59,079
-10,974
-16% -$1.53M 0.02% 628
2019
Q1
$9.19M Buy
70,053
+3,899
+6% +$480K 0.03% 563
2018
Q4
$7.18M Buy
66,154
+2,063
+3% +$276K 0.02% 597
2018
Q3
$9.56M Sell
64,091
-517
-0.8% -$78.6K 0.03% 561
2018
Q2
$9.95M Buy
64,608
+781
+1% +$118K 0.03% 541
2018
Q1
$8.87M Buy
63,827
+5,974
+10% +$878K 0.03% 572
2017
Q4
$7.93M Sell
57,853
-1,399
-2% -$185K 0.03% 611
2017
Q3
$7.69M Buy
59,252
+856
+1% +$114K 0.03% 594
2017
Q2
$7.73M Buy
58,396
+2,139
+4% +$262K 0.03% 571
2017
Q1
$6.92M Sell
56,257
-309
-0.5% -$36.6K 0.03% 579
2016
Q4
$6.24M Buy
56,566
+1,778
+3% +$198K 0.03% 579
2016
Q3
$6.47M Sell
54,788
-23,891
-30% -$2.82M 0.03% 540
2016
Q2
$8.81M Buy
78,679
+5,161
+7% +$555K 0.04% 404
2016
Q1
$7.39M Buy
73,518
+21,555
+41% +$2.07M 0.04% 404
2015
Q4
$5.52M Buy
51,963
+5,240
+11% +$541K 0.03% 519
2015
Q3
$4.35M Sell
46,723
-1,787
-4% -$185K 0.02% 568
2015
Q2
$5.04M Sell
48,510
-25,037
-34% -$2.61M 0.03% 571
2015
Q1
$7.97M Buy
73,547
+45,725
+164% +$4.7M 0.04% 467
2014
Q4
$2.58M Buy
27,822
+8,139
+41% +$719K 0.01% 798
2014
Q3
$1.72M Buy
19,683
+2,571
+15% +$232K 0.02% 822
2014
Q2
$1.51M Buy
17,112
+2,683
+19% +$232K 0.01% 903
2014
Q1
$1.22M Buy
+14,429
New +$1.15M 0.01% 965

Other funds holding LH

Stifel Financial's LH Position: Q1 2026 in Review

Stifel Financial reduced its Labcorp (LH) stake by 14% in Q1 2026, selling an estimated $4.11M and leaving 93,060 shares worth $24.8M. The position accounts for 0.02% of the portfolio, ranked #555.

Stifel Financial first reported a position in LH in Q1 2014 and has held it in 49 quarters since. The position peaked at $140M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Stifel Financial held 93,060 shares of Labcorp worth $24.8M as of Q1 2026.
  • Stifel Financial sold 15,193 Labcorp shares in Q1 2026, an estimated $4.11M.
  • Labcorp made up 0.02% of Stifel Financial's portfolio in Q1 2026, its #555 holding.
  • Stifel Financial first reported a position in Labcorp in Q1 2014 and has held it in 49 quarters since.
  • Stifel Financial's Labcorp position peaked at $140M in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.